BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34036308)

  • 1. Hospital admission as a deprescribing triage point for patients discharged to Residential Aged Care Facilities.
    Roberts G; Pegoli M; Grzeskowiak L; Benger S; Forbes H; Hunt K; Jafari S; Koeper I; McDonald C; Nguyen H; Rawther K; Taeuber L; Tran E; Vu P; Wisdom A; Russell P
    Age Ageing; 2021 Sep; 50(5):1600-1606. PubMed ID: 34036308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective cohort study of nonspecific deprescribing in older medical inpatients being discharged to a nursing home.
    Russell P; Hewage U; McDonald C; Thompson C; Woodman R; Mangoni AA
    Ther Adv Drug Saf; 2021; 12():20420986211052344. PubMed ID: 34707803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational study.
    Aubert CE; Blum MR; Gastens V; Dalleur O; Vaillant F; Jennings E; Aujesky D; Thompson W; Kool T; Kramers C; Knol W; O'Mahony D; Rodondi N
    CMAJ Open; 2023; 11(1):E170-E178. PubMed ID: 36854455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy.
    McIntyre C; McQuillan R; Bell C; Battistella M
    Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deprescribing Medications Among Older Adults From End of Hospitalization Through Postacute Care: A Shed-MEDS Randomized Clinical Trial.
    Vasilevskis EE; Shah AS; Hollingsworth EK; Shotwell MS; Kripalani S; Mixon AS; Simmons SF
    JAMA Intern Med; 2023 Mar; 183(3):223-231. PubMed ID: 36745422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deprescribing in geriatric inpatients is associated with a lower readmission risk: a case control study.
    Hellemans L; Hias J; Walgraeve K; Flamaing J; Spriet I; Tournoy J; Van der Linden L
    Int J Clin Pharm; 2020 Oct; 42(5):1374-1378. PubMed ID: 32803558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deprescribing opportunities for elderly inpatients in an academic, safety-net health system.
    Bredhold BE; Deodhar KS; Davis CM; DiRenzo BM; Isaacs AN; Campbell NL
    Res Social Adm Pharm; 2021 Mar; 17(3):541-544. PubMed ID: 32402730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia.
    Qi K; Reeve E; Hilmer SN; Pearson SA; Matthews S; Gnjidic D
    Int J Clin Pharm; 2015 Oct; 37(5):949-57. PubMed ID: 26047944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deprescribing to optimise health outcomes for frail older people: a double-blind placebo-controlled randomised controlled trial-outcomes of the Opti-med study.
    Etherton-Beer C; Page A; Naganathan V; Potter K; Comans T; Hilmer SN; McLachlan AJ; Lindley RI; Mangin D
    Age Ageing; 2023 May; 52(5):. PubMed ID: 37247404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patient-centered deprescribing intervention for hospitalized older patients with polypharmacy: rationale and design of the Shed-MEDS randomized controlled trial.
    Vasilevskis EE; Shah AS; Hollingsworth EK; Shotwell MS; Mixon AS; Bell SP; Kripalani S; Schnelle JF; Simmons SF;
    BMC Health Serv Res; 2019 Mar; 19(1):165. PubMed ID: 30871561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community.
    Bergler U; Ailabouni NJ; Pickering JW; Hilmer SN; Mangin D; Nishtala PS; Jamieson H;
    Trials; 2021 Nov; 22(1):766. PubMed ID: 34732234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of deprescribing rounds on discharge prescriptions: an interventional trial.
    Edey R; Edwards N; Von Sychowski J; Bains A; Spence J; Martinusen D
    Int J Clin Pharm; 2019 Feb; 41(1):159-166. PubMed ID: 30478496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deprescribing versus continuation of chronic proton pump inhibitor use in adults.
    Boghossian TA; Rashid FJ; Thompson W; Welch V; Moayyedi P; Rojas-Fernandez C; Pottie K; Farrell B
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011969. PubMed ID: 28301676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are residents of aged care facilities willing to have their medications deprescribed?
    Kalogianis MJ; Wimmer BC; Turner JP; Tan EC; Emery T; Robson L; Reeve E; Hilmer SN; Bell JS
    Res Social Adm Pharm; 2016; 12(5):784-8. PubMed ID: 26850702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between deprescribing from polypharmacy and functional recovery and home discharge among older patients with sarcopenia after stroke.
    Kose E; Matsumoto A; Yoshimura Y
    Nutrition; 2023 Jul; 111():112040. PubMed ID: 37141661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MedSafer Study-Electronic Decision Support for Deprescribing in Hospitalized Older Adults: A Cluster Randomized Clinical Trial.
    McDonald EG; Wu PE; Rashidi B; Wilson MG; Bortolussi-Courval É; Atique A; Battu K; Bonnici A; Elsayed S; Wilson AG; Papillon-Ferland L; Pilote L; Porter S; Murphy J; Ross SB; Shiu J; Tamblyn R; Whitty R; Xu J; Fabreau G; Haddad T; Palepu A; Khan N; McAlister FA; Downar J; Huang AR; MacMillan TE; Cavalcanti RB; Lee TC
    JAMA Intern Med; 2022 Mar; 182(3):265-273. PubMed ID: 35040926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.
    Curtin D; Dukelow T; James K; O'Donnell D; O'Mahony D; Gallagher P
    Eur J Clin Pharmacol; 2019 Mar; 75(3):427-432. PubMed ID: 30421220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polypharmacy, Medication Possession, and Deprescribing of Potentially Non-Beneficial Drugs in Hospice Patients.
    Duncan I; Maxwell TL; Huynh N; Todd M
    Am J Hosp Palliat Care; 2020 Dec; 37(12):1076-1085. PubMed ID: 32662276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of elderly patients with polypharmacy who refuse to participate in an in-hospital deprescribing intervention: a retrospective cross-sectional study.
    Komagamine J; Sugawara K; Hagane K
    BMC Geriatr; 2018 Apr; 18(1):96. PubMed ID: 29665778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process.
    Farrell B; Tsang C; Raman-Wilms L; Irving H; Conklin J; Pottie K
    PLoS One; 2015; 10(4):e0122246. PubMed ID: 25849568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.